Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Navamedic
Deal Size : Undisclosed
Deal Type : Agreement
Navamedic ASA Acquires Innovative Antibiotic Product for Hospital Use in The Nordic Region
Details : Clindamycin is a well-established antibiotic used in treatment of severe infections, including staphylococcal bone and joint infections, chronic sinusitis and infections of the lower respiratory tract.
Product Name : Clindamycin-Generic
Product Type : Miscellaneous
Upfront Cash : Undisclosed
November 23, 2022
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Navamedic
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
May 11, 2018
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
January 18, 2018
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
April 07, 2016
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
November 30, 2015
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
November 03, 2015
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
October 16, 2015
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
DUAC® Early Onset Efficacy Study in Japanese Subjects
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
September 23, 2015
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
August 04, 2015
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Clindamycin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
June 08, 2015
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
